Jason E. Comer, PhD

Assistant Professor, Department of Microbiology and Immunology
Study Director, Institutional Office of Regulated Nonclinical Studies

Education:

  • PhD in Experimental Pathology
    |2006| University of Texas Medical Branch, Galveston, TX
  • Master of Science in Biology
    |2001| Duquesne University, Pittsburgh, PA
  • Bachelor of Science in Biology
    |1997| Washington and Jefferson College, Washington, PA

Overview:

Dr. Comer has more than thirteen years of research experience in bacterial pathogenesis, medical countermeasure discovery/testing, and animal model development. Dr. Comer collaborates with UTMB Principle Investigators to design and execute regulated nonclinical studies which includes developing study protocols and standard operating procedures. He ensures regulated studies adhere to the required standards, approves the study data and serves as a single point of control for GLP studies. Before joining UTMB, Dr. Comer served as a Study Director, conducting GLP-compliant studies to test medical countermeasures against select agents at Battelle in Columbus, OH As a study director, he has been involved in developing animal models of infectious disease that are used to evaluate vaccines and therapeutics according to the FDA’s animal rule. He has also designed and directed GLP-compliant studies to test the efficacy of medial countermeasures to a variety of select agents in several animal models including non-human primates (NHPs). Dr. Comer animal models of inhalational anthrax, pneumonic plague and tularemia to test countermeasures under several indications, including general use prophylactics, post-exposure prophylactics and therapeutic intervention.Data from these studies have been submitted to the FDA for animal model development data packages and for evaluation of safety and efficacy supporting product licensure under the FDA "Animal Efficacy Rule". Data generated during studies where Dr. Comer served as Study Director have been presented at national and international meetings and will be part of licensure applications submitted to the FDA.

Research interests:

Dr. Comer is interested in the development of infectious disease models that can be used to evaluate the vaccines and therapeutics under the standards set by the United States Food and Drug Administration (FDA). Dr. Comer serves as a Study Director and plans and oversees preclinical studies to ensure they meet the FDA regulations. His end goal is to facilitate the FDA licensure of new vaccines and therapeutics against bio-threat agents and newly emerging diseases.

Jason E. Comer, PhDjscomer@utmb.edu
Phone: (409) 266-6915
Fax: (409) 266-9565
Route: 0184